FUNDAMENTALS · Fundamentals · JP Basic Materials

Toho Acetylene (4093) Fundamentals 2026 — P/E 11.5x, Revenue Analysis | SniperIQ

Toho Acetylene (4093) is a JP-listed Basic Materials company in Chemicals with a market capitalization of ¥14.8B, trading at ¥425.00 on the JPX. This SniperIQ fundamentals page covers Toho Acetylene's valuation (P/E 11.5x, P/B 0.8x), profitability (net margin 3.7%), revenue (¥34.6B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap¥14.8B
P/E (TTM)11.5x
Net Margin3.7%
Revenue (FY25)¥34.6B

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is Toho Acetylene's market cap?

Toho Acetylene (4093) has a market capitalization of approximately ¥14.8B, trading at ¥425.00 on the JPX. Market cap moves with the live share price.

What is Toho Acetylene's P/E ratio?

Toho Acetylene's trailing twelve-month P/E ratio is 11.5x, with a price-to-book (P/B) of 0.8x. Valuation multiples are best compared with Basic Materials sector peers rather than read in isolation.

How profitable is Toho Acetylene?

Toho Acetylene runs a net profit margin of 3.7%, a gross margin of 32.5%, and an operating margin of 5.5%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Toho Acetylene generate?

Toho Acetylene reported revenue of ¥34.6B for fiscal year 2025, with net income of ¥1.3B and earnings per share (EPS) of 36.99. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Toho Acetylene pay a dividend?

Toho Acetylene offers a trailing dividend yield of about 3.3%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.

Is Toho Acetylene financially healthy?

Toho Acetylene carries a debt-to-equity ratio of 0.20x and a current ratio of 1.85x, with a market beta of 0.54. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Toho Acetylene a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Toho Acetylene (4093) the key facts are: market cap ¥14.8B, P/E 11.5x, revenue ¥34.6B, 52-week range 343-505. Weigh valuation, profitability, growth, and balance-sheet strength against Basic Materials peers and form your own view.

Track Toho Acetylene's full fundamentals live

Get Toho Acetylene's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: Lianhe Chemical Technology (002250) fundamentals · IFGL Refractories (IFGLEXPOR) fundamentals · Chinyang Poly Urethane (010640) fundamentals · Anhui Truchum Advanced Materials and Technology (002171) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons